The largest database of trusted experimental protocols

P450 glotm assay

Manufactured by Promega
Sourced in United States

The P450-GloTM Assay is a luminescent-based assay system designed to detect and measure the activity of cytochrome P450 enzymes. The assay uses a luminogenic CYP450-specific substrate that, when metabolized by an active CYP450 enzyme, generates a light signal proportional to the CYP450 activity.

Automatically generated - may contain errors

4 protocols using p450 glotm assay

1

Cytochrome P450 Activity Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
CYP1A2 (V8422), CYP2B6 (V8322), CYP2C9 (V8792), and CYP3A4 (V9002) activity were measured using P450-GloTM assay purchased from Promega. The measurement of each CYP activity was conducted according to the manufacturer’s protocol. After treatment with inducers or inhibitors, the culture medium was replaced with a fresh medium containing luciferin substrates and incubated at 37 °C with 5% CO2. After incubation, 50 µL of substrate medium was aspirated and transferred to a 96-well white flat-bottom plate (Corning). Luciferin detection reagent (50 µL) was added to each well to initiate a luminescent reaction. The resulting luminescence was measured using a microplate reader (Synergy HTX; BioTek).
+ Open protocol
+ Expand
2

Assessing CYP3A Activity in 3D PHH Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
CYP3A activity of 3D PHH cultures was determined using the P450-GloTM Assay (Promega) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
3

Quantification of CYP4A1 and CYP4F3 Activities

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thoracic aortas were homogenized in ice-cold PBS with 2 μg/ml protease inhibitors. Total protein amount was determined by Qubit fluorometric quantitation (Thermo Fisher Scientific). Assays for activity of CYP4A1 and CYP4F3 were performed using the instructions in the P450-GloTM Assay (Promega, Madison, WI, United States). Biochemical assays were assembled and performed in opaque white 96-well plates, and reactions were incubated with specific CYP substrates 100 μM Luciferin-ME (CYP4A1) or 50 μM Luciferin-4F2/3 (CYP4F3) for 30 min at 37°C. After incubation period, 50 μl of Luciferin Detection Reagent was added to each well to terminate the reaction and initiate luminescence. Luminescence was detected every 5 min for 30 min using a Synergy multi-mode plate reader (BioTek Instruments, Winooski, VT, United States). Data was normalized by the amount of protein in each sample and expressed as the percentage (%) of luminescence emitted by recombinant human CYP4A1 or CYP43F with P450 reductase (SupersomesTM, BD Biosciences). In another series of experiments, the concentration of 20-HETE was determined in aortic homogenates with a commercially available ELISA kit (Detroit R&D, Detroit, MI, United States). 20-HETE levels were expressed as ng/ml and normalized by the total amount of protein.
+ Open protocol
+ Expand
4

Measuring CYP1A2 Activity in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
CYP1A2 enzyme activity in HepG2 cells and Huh7 cells treated with lansoprazole, with or without hsa-miR-132-5p synthetic miRNA mimic, was measured using the substrate-specific P450-GloTM Assay (Promega, Madison, WI). To verify the specific inhibitory effects of the hsa-miR-132-5p mimic, CYP2B6 and CYP3A4 enzyme activities were also measured as negative controls. HepG2 cells and Huh7 cells were seeded at a density of 2 × 104 per well in 96-well plates. After being incubated overnight, synthetic hsa-miR-132-5p mimic together with negative control miRNA mimic were transfected into HepG2 cells and Huh7 cells using Lipofectamine 2000 reagent. After incubation at 37 °C in a CO2 incubator for 6 h, the transfection medium was exchanged with fresh medium containing lansoprazole (50 μM) and then incubated for a period of 12 h. The cells were washed with PBS twice and incubated with 50 μL of fresh culture medium containing the corresponding CYP1A2 substrate (Luciferin-1A2), CYP2B6 substrate (Luciferin-2B6), or CYP3A4 substrate (Luciferin-IPA) at 37 °C for 1 h. Then 25 μl of culture medium was transferred to a white 96-well plate together with 25 μL of luciferin detection reagent added in each well. The luminescence was measured with a BioTek Cytation 5 (BioTek, Winooski, VT) cell imaging multimode reader.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!